Stay updated with breaking news from Adela Inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Adela, Inc., an innovator in blood testing for minimal residual disease monitoring and early cancer detection through a proprietary genome-wide...
NEW HAVEN, Conn., October 12, 2023--BioCT is delighted to announce the appointment of David Scheer as Co-Chair of its Board of Directors. With a distinguished career in the life sciences industry and extensive experience in building successful companies, David brings invaluable expertise to his new leadership role within BioCT.
GUILFORD, Conn., July 12, 2023 (GLOBE NEWSWIRE) -- AI Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics for rare diseases, announced today the appointment of David Scheer as Chairman
The multicancer early detection platform was developed based on methylation of cell-free DNA
An experimental blood test may be able to catch a dozen different types of cancer with a high degree of accuracy -- including some that are particularly tricky to detect, a preliminary study suggests.